Denmark, the first European country to stop using the AstraZeneca coronavirus vaccine in April, announced today that it will do the same with Johnson & Johnson’s monosodium vaccine, due to potential serious side effects.
The European Medicines Agency (EMA) and the World Health Organization have given the green light to these vaccines. “The Danish National Health Administration has concluded that the benefits of using Johnson & Johnson’s Covid-19 vaccine do not outweigh the risk of a potential side effect, VITT (a very rare type of thrombosis), in people receiving the vaccine. “As a result, the Danish Covid-19 mass vaccination program will continue without the Johnson & Johnson vaccine,” the statement said, according to APE-MPE.
To date, Denmark has not approved the use of the Janssen vaccine in Europe. Today’s decision is expected to delay the immunization campaign in a country where the pandemic is believed to have been “under control” for the past four weeks. Most people in high-risk groups, as well as health care workers, are already vaccinated with other drugs. According to the latest announcement, 23.4% of Danes received the first dose of the vaccine and 11.5% the second.
Four Covid-19 vaccines are currently in use in Europe: Pfizer-BioNTech, Moderna, AstraZeneca and Johnson & Johnson.